Corrigendum to "Simplifying paediatric immunization with a fully liquid DTP-HepB-Hib combination vaccine: Evidence from a comparative time-motion study in India" [Vaccine 27 (2009) 655-659] (DOI:10.1016/j.vaccine.2008.11.045);Simplifying paediatric immunization with a fully liquid DTP-HepB-Hib combination vaccine: Evidence from a comparative time-motion study in India

Vaccine

Volumn 27, Issue 5, 2009, Pages 655-659

  Wiedenmayer, Karin A ^a   Weiss, Svenja ^a   Chattopadhyay, Chandon ^b,c   Mukherjee, Ajoy ^b   Kundu, Ritabrata ^c   Ayé, Raffael ^a   Tediosi, Fabrizio ^a   Hetzel, Manuel W ^a   Tanner, Marcel ^a  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b SB Devi Charity Home   (India)

^c INSTITUTE OF CHILD HEALTH   (India)

Author keywords

Childhood vaccine; Pentavalent vaccine; Time motion study

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; EASYFIVE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; ORAL POLIOMYELITIS VACCINE; UNCLASSIFIED DRUG;

ARTICLE; CHILD; CONTROLLED STUDY; DRUG FORMULATION; DRUG TOLERABILITY; FEMALE; FEVER; HUMAN; INDIA; INFANT; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE SWELLING; KINESIOLOGY; LIQUID; LYOPHILISATE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; TERTIARY HEALTH CARE; TIME MOTION STUDY; VACCINATION;

EID: 58249101403     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.04.060     Document Type: Erratum

References (27)

1. WHO. Immunization against diseases of public health importance. Fact sheet N°288. Geneva: World Health Organization; March 2005.
2. CDC. Achievements in public health, 1990-1999: impact of vaccines universally recommended for children - United States, 1990-1998. MMWR Morb Mortal Wkly Rep 48 (1999) 243-248
3. WHO. Pertussis vaccines-WHO position paper. Wkly Epidemiol Rec 80 January (4) (2005) 31-39
4. WHO, UNICEF. Global immunization data. World Health Organization and UNICEF; October 2007.
5. GAVI. GAVI Alliance Strategy (2007-10). Global Alliance for Vaccines and Immunization; June 6, 2006.
6. WHO, UNICEF. Global Immunization Vision and Strategy 2006-2015. Geneva and New York: World Health Organization and UNICEF; 2005.
7. WHO. The children's vaccine initiative and the global programme for vaccines and immunization-recommendations from the special advisory group of experts, Part I. Wkly Epidemiol Rec 71 (1996) 261-266
8. CDC. Combination vaccines for childhood immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP). MMWR Morb Mortal Wkly Rep 48 RR-5 (1999) 1-15
9. Choo S., and Finn A. Pediatric combination vaccines. Curr Opin Pediatr 11 February (1) (1999) 14-20
10. Halsey N. Combination vaccines: defining and addressing current safety concerns. Clin Infect Dis 33 December (s4) (2001) S312-S318
11. Kalies H., Grote V., Verstraeten T., Hessel L., Schmitt H.J., and von K.R. The use of combination vaccines has improved timeliness of vaccination in children. Pediatr Infect Dis J 25 June (6) (2006) 507-512
12. Gatchalian S., Reyes M., Bernal N., et al. A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth. Hum Vaccin 1 September (5) (2005) 198-203
13. Riedemann S., Reinhardt G., Jara J., et al. Immunogenicity and reactogenicity of combined versus separately administered DTPw-HBV and Hib vaccines given to healthy infants at 2, 4 and 6 months of age, with a booster at 18 months. Int J Infect Dis 6 September (3) (2002) 215-222
14. Win K.M., Aye M., Htay-Htay H., Safary A., and Bock H. Comparison of separate and mixed administration of DTPw-HBV and Hib vaccines: immunogenicity and reactogenicity profiles. Int J Infect Dis 2 2 (1997) 79-84
15. Novartis Vaccines, Berna. Mini Monograph. Quinvaxem (TM) DTP-HepB-Hib fully liquid combined vaccine; 2007.
16. Kanra G., Kara A., Demiralp O., et al. Safety and immunogenicity of a new fully liquid DTPw-HepB-Hib combination vaccine in infants. Hum Vaccin 2 July (4) (2006) 155-160
17. IAP. IAP guidebook on immunization. Indian Academy of Pediatrics; 2001.
18. WHO, Guidelines for estimating costs of introducing new vaccines into the national immunization system. Vol. WHC/V&B/02.11, Geneva: World Health Organization; 2002. p. 43.
19. Sewell E.C., Jacobson S.H., and Weniger B.G. "Reverse engineering" a formulary selection algorithm to determine the economic value of pentavalent and hexavalent combination vaccines. Pediatr Infect Dis J 20 November (11 Suppl.) (2001) S45-S56
20. Adam T., Amorim D.G., Edwards S.J., Amaral J., and Evans D.B. Capacity constraints to the adoption of new interventions: consultation time and the Integrated Management of Childhood Illness in Brazil. Health Policy Plan 20 December (Suppl. 1) (2005) i49-i57
21. Miller D.E., Grainger W.L., Woolard D., Timko J.R., and Adler D.C. An economic comparison of Tubex injection systems with traditional ampuls and vials. Hosp Pharm 20 August (8) (1985) 584-591 595
22. Wiedenmayer K, Tediosi F, Weiss S, et al. Improving efficiency using a fully liquid combination vaccine: evidence from a time-motion study in India. 5th World Congress of the World Society for Pediatric Infectious Diseases, Bangkok, November 15-18, 2007; 2007.
23. CDC. Injection practices among nurses - Valcea, Romania 1998. MMWR Morb Mortal Wkly Rep 50 4 (2001 59-61)
24. Olson R.K., Voorhees R.E., Eitzen H.E., Rolka H., and Sewell C.M. Cluster of postinjection abscesses related to corticosteroid injections and use of benzalkonium chloride. West J Med 170 March (3) (1999) 143-147
25. Selenic D., Dodson D.R., Jensen B., Arduino M.J., Panlilio A., and Archibald L.K. Enterobacter cloacae bloodstream infections in pediatric patients traced to a hospital pharmacy. Am J Health Syst Pharm 60 July (14) (2003) 1440-1446
26. Siegrist C.A. Mechanisms underlying adverse reactions to vaccines. J Comp Pathol 137 July (Suppl. 1) (2007) S46-S50
27. TechNet. New Delhi Consultation report. TECHNET21//04.01; 2001.